Wantai BioPharm
Wantai BioPharm, founded in 1991, is a leading high-tech enterprise specializing in the research, development, and production of biological diagnostic tests and vaccines. Committed to our mission of "Advancing Human Health Through Biotechnology", we translate cutting-edge scientific innovations into reliable, high-quality healthcare solutions that benefit communities worldwide.
The company operates through seven specialized subsidiaries, forming an integrated biotechnology ecosystem.
Our research leadership was formally recognized in 2005 when the Ministry of Science and Technology endorsed the establishment of the National Institute of Diagnostics and Vaccine Development (NIDVD) - a landmark collaboration between Xiamen University and Yangshengtang Group, Wantai BioPharm's parent company.
This premier research center functions as both an industrial incubator and innovation accelerator, driving cutting-edge R&D with global impact.
Core Values
Championing Sustainable Innovation in Biopharmaceuticals
For three decades, Wantai BioPharm has evolved from a domestic pioneer to a globally recognized biopharmaceutical leader, seamlessly integrating end-to-end capabilities across R&D, manufacturing, and commercialization. Our expertise is validated by participation in over 60 national-level initiatives, with particular distinction in infectious disease diagnostics and vaccine development.
Through sustained R&D investment and pipeline acceleration, we maintain an innovation-first philosophy. Strategic collaborations with premier research institutions and healthcare organizations worldwide enable us to deliver transformative solutions—from advanced disease prevention protocols to cutting-edge early detection technologies—that address pressing global health challenges.
Positioning
Focusing on the R&D, production, and deployment of diagnostic tests, vaccines and medical instruments.
Aim
Built on Quality, Powered by Innovation
Mission
Advancing the Frontiers of Human Health
Our Influence
Through its exceptional R&D expertise, cutting-edge manufacturing technologies, and comprehensive global reach, the company has established itself as a transformative force in biomedicine.
Global Footprint
80+
The Countries/Regions We Serve Worldwide
Wantai BioPharm's products have achieved worldwide distribution across more than 80 countries, spanning both established markets (including the US, UK, Germany and France) and high-growth economies (such as Malaysia, Indonesia, Iran, India and Brazil). Our global health leadership is further demonstrated through strategic, long-term collaborations with premier international organizations including Médecins Sans Frontières, the World Health Organization, and the Bill & Melinda Gates Foundation - partnerships that amplify our collective impact on public health worldwide.
The Spirit of Wantai
4000
Employees
Guided by its core principles of health innovation, uncompromising quality, and international collaboration, Wantai BioPharm drives meaningful advancements in global public health. Through strategic alliances with leading research institutions and healthcare enterprises worldwide, the company continuously strengthens its technological capabilities and market leadership. Committed to elevating healthcare standards across borders, Wantai is shaping the future of biomedicine as an emerging global industry leader.
Global Partners
Quality at the Core, Customers at Heart
Wantai BioPharm is committed to uncompromising compliance with international quality standards.
Continuous Innovation, Sustainable Progress
Driven by innovation, we continuously pioneer new products and refine our portfolio
Social Responsibility, Building the Future Together
Wantai BioPharm takes active responsibility in serving society.
Filing Number:（京）网药械信息备字（2023）第00164号
Copyright©Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
|
|
京公网安备11011402010353号 
Alibaba Cloud provides cloud computing and security services.|
It supports
|
Powered by CloudDream
|
Terms Of Use|
Privacy Statement